Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 24 for “"FK866"”.
-
Deciphering mechanisms of resistance to FK866 in cancer cells
… NAD(H) lowering agents, as the NAMPT inhibitor FK866, an appealing approach for anticancer therapy. Like other anticancer small molecules, FK866 triggers chemoresistance, observed in several cancer cellular models, which can prevent its clinical application. Here, we unravel molecular mechanisms …
-
Characterisation of Pharmacological Mechanisms and Potential Therapeutic uses of FK866
… targets for drug development. Recently, FK866, a potent inhibitor of nicotinamide phosphoribosyltransferase (Nampt) an important enzyme in the NAD+ rescue pathway, has been evaluated in clinical trials against cancer. The aim of this study is to further investigate the mechanisms and …
-
Molecular Effects of the Nampt Inhibitor FK866 on Leukemia Cells
… thus considered a promising anti-cancer target. FK866 is a specific NAMPT inhibitor that lowers NAD+ concentration in cancer cells, reducing the activity of NAD+-dependent enzymes, impacting on ATP production and promoting cell death. NAMPT inhibition was proven to be highly effective in both …
-
Molecular Mechanisms and Insights into the Nampt Inhibitor (FK866) Resistance in Cancers
… target for treating cancer. The NAMPT inhibitor (FK866) has exhibited anticancer activity in several preclinical models by depleting NAD+ and ATP levels. Recently, we showed that FK866 induced translation arrest through the activation of 5’AMP-activated protein kinase (AMPK), inhibition of …
-
Preparación, aplicaciones y reactividad de nuevos derivados de iminoazúcares. Síntesis de análogos del FK866 con propiedades anticáncer
… de nuevos análogos del compuesto antitumoral FK866. Estos derivados incorporan uno o dos átomos de flúor o cloro en el anillo de piridina con el objetivo de minimizar la N-oxidación in vivo del compuesto de referencia (FK866), mejorando su biodisponibilidad. Adicionalmente, incorporan …
-
The NAMPT-mediated NAD salvage pathway in cancer cell metabolism and its regulation by resveratrol
… potential and molecular mechanisms of FK866, a specific NAMPT inhibitor, and resveratrol on hepatocarcinoma cells and to find out whether there are differences compared to primary human hepatocytes; (2) to address the impact of NAMPT inhibition on the energy metabolism in cancer cells; …
-
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
… was inhibited by applying its specific inhibitor FK866 in hepatocarcinoma cells to investigate whether or not NAMPT inhibition could be a potential novel therapeutic approach in HCC treatment. Hepatocarcinoma cells were more sensitive to NAMPT inhibition by FK866 than primary human hepatocytes, …
-
Targeting iNAMPT to Break the Obesity-Associated Liver Cancer Link: An In Vitro and In Vivo Approach
… diet-induced obesity (OB) or control chow (CR) + FK866 (iNAMPT inhibitor) in SNU, HepG2 human liver cancer cells and Hepa 1-6 murine cells. Analysis of proteins pAkt and pERK was performed by immunoblot. Proliferation, ROS, cytotoxicity, and invasion were also measured in liver cancer cells. For …
-
A Machine Learning-Based Histopathological Image Analysis Reveals Cancer Stemness in TNBCs with 17p Loss
… of 17p-loss cancer cells, one of which is FK866. FK866 promoted the antitumor activity of doxorubicin in the treatment of 17p-loss TNBCs. Our study provides a powerful computational tool for cancer image analysis as well as a feasible approach for precision cancer medicine.
-
METABOLOMIC STUDIES OF HEART DISEASE, CHRONIC KIDNEY DISEASE AND HUMAN CANCER CELL LINE
… acidosis in the pathophysiology of CKD. Lastly, FK866 and GMX1778 inhibition on NAMPT shows different metabolic changes in prostate cancer cell, demonstrating metabolomics is a useful tool in pharmacological studies.
-
Modulation of innate immune cells by the NAD+ pathway
… with TNF-α release, three inhibitors (FK866, DPI and 1D-MT) were used. Following stimulation, NAD+ is produced partially via NADH oxidation and partially through NAD+ synthesis. Both DPI and FK866 reduced TNF-α secretion with DPI showing the largest effect. The two phenotypes showed …
-
Targeting nicotinamide adenine dinucleotide metabolism for the treatment of chronic lymphocytic leukemia
… interactions between the NAMPT inhibitors FK866 and GMX-1778, and chemotherapeutics and targeted agents in current clinical use, as well as agents targeting mitochondrial metabolism, glycolysis and oxidative stress. We identified several promising novel drug combinations for further …
-
Protective effect of Nicotinamide on High glucose (HG)/Palmitate (PA)-induced Glucolipotoxicity to INS-1 beta cells
… of NAD salvage pathway by Nampt inhibitor FK866 or knocking down the Nampt or knocking down the Nmnat did not protect against HG/PA-induced cell death. Furthermore, FK866 did not reduced NAM-induced protective effects. Third, We have investigated whether NAM has protective effect against …
-
NAD+ and the metabolism of cellular glucocorticoids in endoplasmic reticulum
… NAD(P)(H). Here we depleted cellular NAD+ using FK866 (NAMPT inhibitor) and poly-ADP-ribose assisted protein localization assay to study ER-specific NAD+ metabolism using 11β-HSD1 as a readout. To assess the generalizability of our results, we examined the enzyme activity in multiple cell types …
-
Role of activity in neuromuscular synaptic degeneration: insights from Wlds mice
… tested the effects of NAMPT enzymatic inhibitor FK866 on synaptic degeneration. Interestingly, the synaptic protection observed in Wlds muscles was enhanced in the presence of FK866. The results of my findings are relevant to understanding the plasticity of synapses and its relationship to …
-
Adaptations to skeletal muscle metabolism in response to altered NAD\(^+\) bioavailability
… metabolism, suggesting differential effects of FK866 treatment on sub-cellular pyridine pools. Overall the work highlighted how core carbon metabolic pathways are able to adapt to differing NAD\(^+\) bioavailability in skeletal muscle.
-
Polystyrene coated iron-platinum drug delivery platforms for theranostics
… Furthermore, there are numerous drugs such as FK866, doxorubicin, gemcitabine, and paclitaxel that are used to treat various types of cancer. Many of these drugs have different mechanisms by which they cause cell death. New derivatives of FK866, considered to be one of the most potent …
-
Modulating NAMPT activity to improve beta-cell survival and function in type 1 diabetes
… small molecule iNAMPT inhibitors (termed C17 or FK866) and activators (P7C3 or SBI) to determine if iNAMPT plays a role in cytokine-mediated β-cell survival, function, and transcriptome changes in vitro. Cytokine-mediated apoptosis, necrosis, dysfunction, and differential gene expression were …
-
The effects of the adipocyte-secreted proteins resistin and visfatin on the pancreatic beta-cell
… and were reversed by visfatin inhibitor FK866. Visfatin treatment at low concentrations did not have any effect on cell viability however the elevated concentrations resulted in a decline. These data indicate that both resistin and visfatin potentially play important roles in beta-cell …
-
The Identification and Targeting of Altered NAD+ Metabolism in Glioblastoma
… inhibition of the salvage pathway with FK866 sustained β-lapachone mediated NAD+ depletion and combination led to synergistic toxicity. These results identified NQO1 expression as a potential marker of susceptibility to β-lapachone. We next investigated targeting of ribose synthesis, the …
Page 1 of 2